These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14644067)

  • 1. Comparison of HPA axis hormonal responses to naloxone vs psychologically-induced stress.
    Oswald LM; Mathena JR; Wand GS
    Psychoneuroendocrinology; 2004 Apr; 29(3):371-88. PubMed ID: 14644067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social setting, social rank and HPA axis response in cynomolgus monkeys.
    Jimenez VA; Allen DC; McClintick MN; Grant KA
    Psychopharmacology (Berl); 2017 Jun; 234(12):1881-1889. PubMed ID: 28332004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
    Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
    Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
    Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
    J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis and ethanol modulation of deoxycorticosterone levels in cynomolgus monkeys.
    Porcu P; Grant KA; Green HL; Rogers LS; Morrow AL
    Psychopharmacology (Berl); 2006 Jun; 186(3):293-301. PubMed ID: 16133132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress.
    Chong RY; Oswald L; Yang X; Uhart M; Lin PI; Wand GS
    Neuropsychopharmacology; 2006 Jan; 31(1):204-11. PubMed ID: 16123758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity.
    Uhart M; Chong RY; Oswald L; Lin PI; Wand GS
    Psychoneuroendocrinology; 2006 Jun; 31(5):642-52. PubMed ID: 16616815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covariance between psychological and endocrine responses to pharmacological challenge and psychosocial stress: a question of timing.
    Schlotz W; Kumsta R; Layes I; Entringer S; Jones A; Wüst S
    Psychosom Med; 2008 Sep; 70(7):787-96. PubMed ID: 18725434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol and adrenocorticotropic hormone responses to naloxone in subjects with high and low neuroticism.
    Mangold DL; Wand GS
    Biol Psychiatry; 2006 Oct; 60(8):850-5. PubMed ID: 16950229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
    Gerra G; Bassignana S; Zaimovic A; Moi G; Bussandri M; Caccavari R; Brambilla F; Molina E
    Psychiatry Res; 2003 Sep; 120(2):115-24. PubMed ID: 14527643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone.
    Adinoff B; Krebaum SR; Chandler PA; Ye W; Brown MB; Williams MJ
    Alcohol Clin Exp Res; 2005 Apr; 29(4):528-37. PubMed ID: 15834217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone augments the hypothalamic-pituitary-adrenal axis response to methylphenidate in normal subjects.
    Joyce PR; Donald RA
    J Psychiatr Res; 1987; 21(3):297-300. PubMed ID: 2824766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute HPA axis response to naltrexone differs in female vs. male smokers.
    Roche DJ; Childs E; Epstein AM; King AC
    Psychoneuroendocrinology; 2010 May; 35(4):596-606. PubMed ID: 19837518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.